Brief: Medacta Sees FY 2023 Adj. EBITDA Margin in Line With 2022
Mar 17 (Reuters) - Medacta FY adjusted EBITDA EUR 120.4 million. * Outlook for 2023: At constant currency, revenue in the range of EUR 480 million to EUR 495 million and adjusted EBITDA margin largely in line with 2022
Recent news on Medacta SA
See all newsBrief: Medacta Group Updates 2026 Guidance, Reiterates 2024-2027 Mid-Term Outlook
Swiss medical device maker Medacta H1 revenue rises on Asia Pacific, EMEA strength
Brief: Medacta H1 Adjusted EBITDA EUR 97 Million
Switzerland's Medacta H1 revenue rises 9.7% in constant currency
Brief: Medacta H1 Revenue EUR 368 Million